Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Stem Cells for Complex Perianal Fistulae
NCT01586715Phase 2Unknown
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Mar 2012
- Primary completion
- May 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adipose derived mesenchymal stromal cells in perianal fistula, sponsored by Hospital La Paz Institute for Health Research. Primary endpoint: Safety of treatment of extremely complex perianal fistulae at 16 weeks. Status: unknown.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
perianal fistula
Beyond the preview
Go deeper on NCT01586715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01586715.